Literature DB >> 11284453

An improved high-performance liquid chromatographic method for the determination of sphingosine-1-phosphate in complex biological materials.

L Ruwisch1, M Schäfer-Korting, B Kleuser.   

Abstract

Sphingosine-1-phosphate (SPP) has been proposed to act both as an intracellular second messenger and as an extracellular mediator via specific cell surface receptors. Based on the increasing diverse cellular roles methods to quantify endogenous and exogenous SPP are highly required. Here, we report a rapid HPLC method that allows quantification of SPP in the picomolar range even in complex biological systems. A two-step lipid extraction serves to separate SPP from most interfering phospholipids and sphingolipids. Importantly, dihydrosphingosine-1-phosphate (dihydro-SPP), not detectable in all cultured cells and biological samples in considerable amounts, possesses equal extraction properties and therefore is an ideal internal standard. Following extraction SPP and dihydro-SPP are converted to fluorescent isoindol derivatives by ortho-phthaldialdehyde (OPA) and separated by HPLC using a gradient program with methanol and 0.07 M K2HPO4 as eluents. With this procedure we were able to obtain reproducible measurements of SPP over a broad range from 0.5 pM to 0.2 nM. The identity of SPP and dihydro-SPP was confirmed by the use of the ion pair reagent tetraammoniumsulfate, which induced a shift of both peaks but did not alter peak areas. Moreover, enzymatic conversions to sphingosine and sphinganine by bovine intestinal mucosa alkaline phosphatase (AP) excluded the existence of overlapping compounds. Levels of SPP were determined in a variety of biological samples like serum, thrombocytes, primary keratinocytes and several cell lines. Furthermore, we were able to detect increases of intracellular SPP levels in human keratinocytes after exposure to 1alpha,25-dihydroxyvitamin D3(1,25-(OH)2D3) for which a stimulation of sphingosine kinase activity has been recognized.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284453     DOI: 10.1007/s002100000365

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  18 in total

1.  Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling.

Authors:  Christina D Keller; Pilar Rivera Gil; Markus Tölle; Markus van der Giet; Jerold Chun; Heinfried H Radeke; Monika Schäfer-Korting; Burkhard Kleuser
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

2.  Determination of sphingosine kinase activity for cellular signaling studies.

Authors:  Katherine J Lee; Simon M Mwongela; Sumith Kottegoda; Laura Borland; Allison R Nelson; Christopher E Sims; Nancy L Allbritton
Journal:  Anal Chem       Date:  2008-01-16       Impact factor: 6.986

Review 3.  Sphingosine 1-phosphate in coagulation and inflammation.

Authors:  Hideru Obinata; Timothy Hla
Journal:  Semin Immunopathol       Date:  2011-07-31       Impact factor: 9.623

4.  Characterization and direct quantitation of sphingoid base-1-phosphates from lipid extracts: a shotgun lipidomics approach.

Authors:  Xuntian Jiang; Xianlin Han
Journal:  J Lipid Res       Date:  2006-05-08       Impact factor: 5.922

5.  S1PR1 Tyr143 phosphorylation downregulates endothelial cell surface S1PR1 expression and responsiveness.

Authors:  Alejandra Chavez; Tracy Thennes Schmidt; Pascal Yazbeck; Charu Rajput; Bhushan Desai; Sukriti Sukriti; Kristina Giantsos-Adams; Nebojsa Knezevic; Asrar B Malik; Dolly Mehta
Journal:  J Cell Sci       Date:  2015-01-14       Impact factor: 5.285

6.  A rapid assay for assessment of sphingosine kinase inhibitors and substrates.

Authors:  Yugesh Kharel; Thomas P Mathews; Andrew J Kennedy; Joseph D Houck; Timothy L Macdonald; Kevin R Lynch
Journal:  Anal Biochem       Date:  2011-01-07       Impact factor: 3.365

7.  Assessment of sphingosine-1-phosphate activity in biological samples by receptor internalization and adherens junction formation.

Authors:  Hideru Obinata; Timothy Hla
Journal:  Methods Mol Biol       Date:  2012

8.  Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.

Authors:  Sutada Lotinun; Riku Kiviranta; Takuma Matsubara; Jorge A Alzate; Lynn Neff; Anja Lüth; Ilpo Koskivirta; Burkhard Kleuser; Jean Vacher; Eero Vuorio; William C Horne; Roland Baron
Journal:  J Clin Invest       Date:  2013-01-16       Impact factor: 14.808

9.  Involvement of the ABC-transporter ABCC1 and the sphingosine 1-phosphate receptor subtype S1P(3) in the cytoprotection of human fibroblasts by the glucocorticoid dexamethasone.

Authors:  Barbara Nieuwenhuis; Anja Lüth; Jerold Chun; Andrea Huwiler; Josef Pfeilschifter; Monika Schäfer-Korting; Burkhard Kleuser
Journal:  J Mol Med (Berl)       Date:  2009-04-17       Impact factor: 4.599

10.  HDL induces NO-dependent vasorelaxation via the lysophospholipid receptor S1P3.

Authors:  Jerzy-Roch Nofer; Markus van der Giet; Markus Tölle; Iza Wolinska; Karin von Wnuck Lipinski; Hideo A Baba; Uwe J Tietge; Axel Gödecke; Isao Ishii; Burkhard Kleuser; Michael Schäfers; Manfred Fobker; Walter Zidek; Gerd Assmann; Jerold Chun; Bodo Levkau
Journal:  J Clin Invest       Date:  2004-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.